ATI-2173 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Neuren Pharmaceuticals (ASX: NEU) gains fourth US orphan drug designation for NNZ-2591

Coursera (NYSE: COUR) plunges 26% as Udemy savings accelerate. Where is the growth?

Trump administration loses Alaska Senate ballot case as judge rejects election delay

Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding

Read More

Pharma Industry News

Antios Therapeutics begins phase 1 trial for ATI-2173, a chronic hepatitis B candidate

US biopharma company Antios Therapeutics has initiated its first-in-human phase 1 clinical trial for ATI-2173, a liver-targeted, orally-administered,…

bypharmanewsdaily

February 13, 2020

web analytics